Modulating Drug Release from Gastric-Floating Microcapsules through Spray-Coating Layers

• Main Authors: Lee, Wei Li, Tan, Jun Wei Melvin, Tan, Chaoyang Nicholas, Loo, Say Chye Joachim
• Other Authors: Mohapatra, Subhra
• Format: Article
• Language: English
• Published: 2016
• Subjects: Coatings; Drug delivery; Polymers; Buoyancy; Drug-drug interaction; Vegetable oils; Drug absorption; Microencapsulation
• Online Access: https://hdl.handle.net/10356/82825; http://hdl.handle.net/10220/40329
• Institution: Nanyang Technological University

Floating dosage forms with prolonged gastric residence time have garnered much interest in the field of oral delivery. However, studies had shown that slow and incomplete release of hydrophobic drugs during gastric residence period would reduce drug absorption and cause drug wastage. Herein, a spray-coated floating microcapsule system was developed to encapsulate fenofibrate and piroxicam, as model hydrophobic drugs, into the coating layers with the aim of enhancing and tuning drug release rates. Incorporating fenofibrate into rubbery poly(caprolactone) (PCL) coating layer resulted in a complete and sustained release for up to 8 h, with outermost non-drug-holding PCL coating layer serving as a rate-controlling membrane. To realize a multidrug-loaded system, both hydrophilic metformin HCl and hydrophobic fenofibrate were simultaneously incorporated into these spray-coated microcapsules, with metformin HCl and fenofibrate localized within the hollow cavity of the capsule and coating layer, respectively. Both drugs were observed to be completely released from these coated microcapsules in a sustained manner. Through specific tailoring of coating polymers and their configurations, piroxicam loaded in both the outer polyethylene glycol and inner PCL coating layers was released in a double-profile manner (i.e. an immediate burst release as the loading dose, followed by a sustained release as the maintenance dose). The fabricated microcapsules exhibited excellent buoyancy in simulated gastric fluid, and provided controlled and sustained release, thus revealing its potential as a rate-controlled oral drug delivery